Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05729685
Other study ID # AERCONINT
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2020
Est. completion date December 10, 2021

Study information

Verified date February 2023
Source Democritus University of Thrace
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this intervention study is to compare the adaptations after a 6-week training period between an intense continuous and a high-intensity interval training program performed under iso-effort conditions on aerobic performance parameters in young healthy adults. The main question it aims to answer are if the intense continuous and a high-intensity interval training programs will induce similar adaptations in maximal (VO2max and PTV) and submaximal (critical velocity, lactate threshold parameters and running economy) aerobic performance parameters. Participants will be ere randomly assigned either to an intense continuous training group (CON) or to a high-intensity interval training group (INT). The training program will comprise of 14 training sessions performed over a 6-week period.


Description:

The aim of this study was to compare the adaptations after a 6-week training period between the intense continuous and the high-intensity interval training methods performed under iso-effort conditions on maximal (VO2max and PTV) and submaximal (critical velocity, lactate threshold parameters and running economy) aerobic performance parameters. A parallel group research design was used in the present study. Initially, 26 participants (10 males and 16 females), using stratified randomization (gender was the variable of stratification) were randomly assigned (1:1), according to a random-number table, either to an intense continuous training group (CON) or to a high-intensity interval training group (INT). The INT group trained using the interval method. During the exercise sessions the participants ran each bout at an intensity corresponding to 90% of PTV. PTV was used to prescribe the exercise intensity at the INT group. The duration of the running-bouts was equal to ΒΌ of the individual time to exhaustion at 90% of PTV (determined during the CV testing) followed by passive rest equal to 2/3 of exercise duration. The duration of the exercise-bouts was individualized based on the time to exhaustion at 90% of PTV to reduce the between subject's variability. The participants terminated each exercise session when an RPE value of 17 was reached. Running bout duration and intensity were adjusted after 7 training sessions (during the 3rd week) following a reassessment of the time to exhaustion at 90% of the "new" PTV achieved during mid-testing as a result of training. The CONT group trained using the continuous method. During the training sessions the participants ran with an intensity corresponding to -2,5% of CV until they reported a rating of 17 at the 6-20 Borg's scale. Running velocity was adjusted after 7 training sessions (during the 3rd week) after reassessment of CV. CV was used to determine the exercise intensity in the CONT group to ensure that all individuals would ran at the heavy intensity domain and be able to complete at least 15 min of continuous running, and to minimize the high inter-individual variations in endurance time at intensities near the upper limit of the heavy intensity domain. Using PTV to determine the intensity in the CONT group, would increase the possibility for trainees to exercise at different exercise intensity domains. During the experiment, participants will not perform any other form of training besides of that applied in the current study. VO2max, PTV, oxygen consumptions, heart rates and the velocities corresponding to the 1st and the 2nd lactate thresholds (LT1 and LT2), the velocity at 4 mmol/L of blood lactate concentration (v4mmol), running economy, and critical velocity (CV) will be measured before, after 7 training sessions (3rd week, two days after the 7th training session), and after the completion of training program.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date December 10, 2021
Est. primary completion date December 10, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion criteria - All participants should have been involved in low intensity continuous training, - All participants should have been training 1-3 times per week for 30-45 min for at least three months. Exclusion criteria - Not familiar with aerobic training - Any health issues that did not allow participation in regular exercise training.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Interval training
The interval training group trained using the interval method. During the exercise sessions the participants ran each bout at an intensity corresponding to 90% of PTV. PTV was used to prescribe the exercise intensity at the INT group. The duration of the running-bouts was equal to ¼ of the individual time to exhaustion at 90% of PTV (determined during the CV testing) followed by passive rest equal to 2/3 of exercise duration. The duration of the exercise-bouts was individualized based on the time to exhaustion at 90% of PTV to reduce the between subject's variability. The participants terminated each exercise session when an RPE value of 17 was reached. Running bout duration and intensity were adjusted after 7 training sessions (during the 3rd week) following a reassessment of the time to exhaustion at 90% of the "new" PTV achieved during mid-testing as a result of training.
Continuous training
The continuous group trained using the continuous method. During the training sessions the participants ran with an intensity corresponding to -2,5% of CV until they reported a rating of 17 at the 6-20 Borg's scale. Running velocity was adjusted after 7 training sessions (during the 3rd week) after reassessment of CV. CV was used to determine the exercise intensity in the CONT group to ensure that all individuals would ran at the heavy intensity domain and be able to complete at least 15 min of continuous running, and to minimize the high inter-individual variations in endurance time at intensities near the upper limit of the heavy intensity domain. Using PTV to determine the intensity in the CONT group, would increase the possibility for trainees to exercise at different exercise intensity domains.

Locations

Country Name City State
Greece Department of Physical Education and Sport Science Komotini Rodopi

Sponsors (1)

Lead Sponsor Collaborator
Ilias Smilios

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in maximal oxygen consumption Maximal oxygen consumption in ml/kg/min At the beginning of the training program, the 3rd week of training (after 7 training sessions), and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
Primary Changes in peak treadmill velocity Peak treadmill velocity using a maximal incremental test to exhaustion on a treadmill in km/h At the beginning of the training program, the 3rd week of training (after 7 training sessions), and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
Primary Changes in running velocities at the 1st and the 2nd lactate thresholds Running velocities (km/h) at the 1st and the 2nd lactate thresholds by measuring the changes in blood lactate concentration during a maximal incremental test to exhaustion on a treadmill. At the beginning of the training program, the 3rd week of training (after 7 training sessions), and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
Primary Changes in critical velocity Critical velocity (km/h) determined by having the participants ran until exhaustion at velocities corresponding to 90, 100, and 110% of peak treadmill velocity. Using linear regression analyses, the relationship between the distance covered at each run and the time to exhaustion was calculated. ?he slope of the linear regression line was the critical velocity. At the beginning of the training program, the 3rd week of training (after 7 training sessions), and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
Secondary Changes in running economy Running economy determined by measuring the oxygen consumption (ml/kg/min) while running for 10 min at a velocity corresponding to 70% of the pre-training peak treadmill velocity At the beginning of the training program and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
Secondary Changes in running velocity at a blood lactate concentration of 4 mmol/L Running velocity (km/h) at a blood lactate concentration of 4 mmol/L determined by the individual relationship between lactate concentrations and running velocities during an incremental test by applying a nonlinear regression model. At the beginning of the training program and the 7th week after the start of the intervention (after the completion of 6 weeks of training, 14 training sessions)
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1